
【レポートの概要(一部)】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Indication
5.1 Introduction
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Lung Cancer
5.5 Others Indications
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Blocking Drug
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Cetuximab
6.2.2 Necitumumab
6.3 Tyrosine Kinase Inhibitors (TKI)
6.3.1 Erlotinib
6.3.2 Gefitinib
7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Amgen Inc
9.2 Bristol-Myers Squibb
9.3 Erbitux
9.4 F. Hoffmann-La Roche Ltd
9.5 Genentech, Inc
9.6 OSI Pharmaceuticals Inc
9.7 Tarceva
9.8 Vectibix
List of Tables
Table 1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 9 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 10 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 11 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 12 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 13 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 14 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 15 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 16 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 17 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 18 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 19 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 20 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 21 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 22 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 23 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 24 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 25 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 26 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 27 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 28 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 29 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 30 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 31 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 32 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 33 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 34 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 35 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 36 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 37 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 38 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 39 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 40 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 42 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 43 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 44 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 45 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 46 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 47 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 48 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 49 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 50 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 51 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 52 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 53 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 54 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 55 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 56 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 57 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 58 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 59 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 60 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 61 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 62 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 63 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 64 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 65 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 66 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 67 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 68 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 69 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 70 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 71 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 72 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 73 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 74 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 75 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 76 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 77 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 78 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
【レポート販売概要】
■ タイトル:上皮増殖因子受容体(EGFR)阻害薬の世界市場展望2017-2026■ 英文:Epidermal Growth Factor Receptor (EGFR) Inhibitors - Global Market Outlook (2017-2026)
■ 発行日:2019年6月
■ 調査会社:Stratistics MRC
■ 商品コード:SMRC90773
■ 調査対象地域:グローバル
- 特殊検査の世界市場2019-2023About this market The increasing prevalence of chronic diseases, such as cancers, among individuals is fueling the demand for the early diagnosis of diseases to offer better patient care. Infections are increasingly caused by pathogens such as bacteria, viruses, fungi, and parasites, resulting in diseases such as hepatitis and herpes as well as urinary tract infections and bladder infections. Anat …
- 対空ミサイル防衛レーダー(AMDR)の世界市場:地上レーダーシステム、航空機搭載レーダーシステム、船舶用レーダーシステムAbout Air and Missile Defense Radar System Radar is an object detection system that detects the range, altitude, direction, speed of the approaching and still objects by using radio waves. It is used to detect missiles, spacecraft's, ships, aircrafts, weather formations, and terrain. They are used as an early-warning devices, to spot foe's approaching missiles and airborne systems from great dista …
- 世界の酪農食品(乳製品)市場のM&A動向(2014年7月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global dairy food market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the partn …
- 2014年戦略提言:ポイントオブケア(POC)脂質検査市場This new 340-page report from Venture Planning Group contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective bu …
- ブレース/支持具/補綴具の世界市場分析および予測MediPoint: Braces and Supports and Prosthetic Devices - Global Analysis and Market Forecasts Summary The global orthotics and prosthetics (O&P) market, which includes braces and supports and prosthetic devices, is an expansive market covering a broad range of indications. Braces and supports, external devices that provide support to joints and weakened musculoskeletal groups to facilitate function …
- データセンター向け冷却ソリューション世界市場2017-2021About Data Center Cooling SolutionsThe services offered by a data center facility can be identified based on a tier system, ranking from one to four, which indicates the physical infrastructure, cooling, power, promised uptime, and redundancy levels in the said facility. Technavio’s analysts forecast the global data center cooling solutions market to grow at a CAGR of 9.95% during the period 2017- …
- 2,5-Bis[(1,3-ジオキソブチル)アミノ]ベンゼンスルホン酸の世界市場2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report 2013 presents comprehensive data on 2,5-bis[(1,3-dioxobutyl)amino]benzenesulfonic acid markets globally and regionally (Europe, Asia, North America etc.) The 2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report 2013 includes 2,5-bis[(1,3-dioxobutyl)amino]benzenesulfonic …
- 体組成計の世界市場予測(~2021年):バイオ・インピーダンス分析装置、DEXA(二重エネルギーX線吸収測定法)、皮脂厚計、ADP(空気置換プレチスモグラフィー)、静水力学的計量装置The body composition analyzers market is expected to reach USD 668.1 Million in 2021 from USD 366.7 Million in 2016 at a CAGR of 12.7%. The demand for body composition analyzers has been on the rise due to the growing obese population across the globe. Other drivers include growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and t …
- リソグラフィー計測機器の世界市場:技術別(CD-SEM、OCD、オーバーレイ制御、その他)、製品別(化学制御機器、ガス制御機器、その他)、用途別(品質管理と検査、リバースエンジニアリング、仮想シミュレーション、その他)The semiconductor industry is continuously witnessing transition such as miniaturization of nodes and wafer sizes. The rise in demand for increasing wafer sizes into ultra-large-scale integration fabrication technology fosters the growth of the lithography metrology equipment market globally. Lithography metrology is a front-end process in semiconductor industry, which is used in fabrication. This …
- 埋め込み型医療デバイスの世界市場:乳房インプラント、歯科インプラント、顔面インプラントAbout implantable medical devices Implantable medical devices are artificial implants used to replace, augment, or repair damaged tissues or organs. They are used in a wide range of applications including cosmetic, spinal, cardiovascular, ophthalmic, and neuro-stimulator implantation surgeries. These implants are made of different materials such as polymers, metals, ceramics, and biologics. Techna …
- 重量式道路ろ過のアフターマーケットの世界市場分析:製品別(オイル、エア、キャビン、燃料)、用途別(トラック・バス、建設、鉱業、農業)、セグメント予測The heavy duty road filtration aftermarket industry is expected to reach USD 1.01 billion by 2024, according to a new report by Grand View Research, Inc. Rising environmental concern across countries coupled with new norms issued by the government is expected to aid the aftermarket sales for heavy duty road filtration products over the forecast period. To curb the alarming effect of air pollution, …
- FieldPoint Petroleum Corporation:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013FieldPoint Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary FieldPoint Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report …
- 自動ゲート・ボラードの世界市場2019-2023About this market Automatic tolling systems or electronic toll collection (ETC) systems are designed to minimize the waiting time on tollways, highways, and bridges by automating the process of toll collection and eliminating the need for cash transactions. An automated barrier is one of the key components of the automatic tolling system. Automatic tolling systems are connected to automated barrie …
- 食品用安定剤の世界市場About Food Stabilizers Food stabilizers are added to stabilize and improve the texture, prevent crystallization (sugar and ice), stabilize foams and emulsions, reduce the stickiness of icings on baked products, and to retain moisture and flavor of food products. Polysaccharide gum, arabic gum, and guar gum are the most commonly used stabilizers and thickeners. Gelatin is another commonly used non- …
- スペインの心臓律動管理(CRM)装置市場見通しSpain Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Spain Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Spain Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT) P …